These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16918384

  • 1. Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats.
    Lee EJ, Wu TS, Chang GL, Li CY, Chen TY, Lee MY, Chen HY, Maynard KI.
    Curr Neurovasc Res; 2006 Aug; 3(3):203-13. PubMed ID: 16918384
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acute Combined Cerebrolysin and Nicotinamide Administration Promote Cognitive Recovery Through Neuronal Changes in the Hippocampus of Rats with Permanent Middle Cerebral Artery Occlusion.
    Martínez-Torres NI, Cárdenas-Bedoya J, Torres-Mendoza BM.
    Neuroscience; 2024 Jun 21; 549():76-83. PubMed ID: 38734304
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q, Stephenson D.
    Exp Neurol; 2002 Oct 21; 177(2):531-7. PubMed ID: 12429198
    [Abstract] [Full Text] [Related]

  • 7. Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats.
    Sakakibara Y, Mitha AP, Ogilvy CS, Maynard KI.
    Neurosci Lett; 2000 Mar 10; 281(2-3):111-4. PubMed ID: 10704755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Delayed multidose treatment with nicotinamide extends the degree and duration of neuroprotection by reducing infarction and improving behavioral scores up to two weeks following transient focal cerebral ischemia in Wistar rats.
    Maynard KI, Ayoub IA, Shen CC.
    Ann N Y Acad Sci; 2001 Jun 10; 939():416-24. PubMed ID: 11462797
    [Abstract] [Full Text] [Related]

  • 10. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats.
    Li F, Omae T, Fisher M.
    Stroke; 1999 Nov 10; 30(11):2464-70; discussion 2470-1. PubMed ID: 10548685
    [Abstract] [Full Text] [Related]

  • 11. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, Ginsberg MD.
    Brain Res; 2001 Jun 29; 905(1-2):81-90. PubMed ID: 11423082
    [Abstract] [Full Text] [Related]

  • 12. Delayed treatment with magnesium: reduction of brain infarction and improvement of electrophysiological recovery following transient focal cerebral ischemia in rats.
    Lee EJ, Lee MY, Chang GL, Chen LH, Hu YL, Chen TY, Wu TS.
    J Neurosurg; 2005 Jun 29; 102(6):1085-93. PubMed ID: 16028768
    [Abstract] [Full Text] [Related]

  • 13. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
    Belayev L, Khoutorova L, Atkins K, Gordon WC, Alvarez-Builla J, Bazan NG.
    Exp Neurol; 2008 Dec 29; 214(2):253-8. PubMed ID: 18793637
    [Abstract] [Full Text] [Related]

  • 14. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression.
    Liu Y, Zhang XJ, Yang CH, Fan HG.
    Brain Res; 2009 May 01; 1268():174-180. PubMed ID: 19285049
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
    Zhang Y, Belayev L, Zhao W, Irving EA, Busto R, Ginsberg MD.
    Brain Res; 2005 May 31; 1045(1-2):150-6. PubMed ID: 15910773
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats.
    Katayama Y, Inaba T, Nito C, Ueda M.
    Neurol Res; 2016 Mar 31; 38(3):275-84. PubMed ID: 27078702
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
    Shaik JS, Ahmad M, Li W, Rose ME, Foley LM, Hitchens TK, Graham SH, Hwang SH, Hammock BD, Poloyac SM.
    Am J Physiol Heart Circ Physiol; 2013 Dec 01; 305(11):H1605-13. PubMed ID: 24043255
    [Abstract] [Full Text] [Related]

  • 20. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
    Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH.
    J Neurol Sci; 2001 Jun 15; 187(1-2):91-7. PubMed ID: 11440750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.